Glucotrack (GCTK) Cash from Operations Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 34.91% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 53.64% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 25.17% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -13.33% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 16.13% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | -8.92% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -23.67% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 6.48% |
| 10 | Glucotrack | 290,858.33 | -7.09 Mn | - | -61.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -61.18% |
| Sep 30, 2025 | -96.61% |
| Jun 30, 2025 | -59.89% |
| Mar 31, 2025 | -32.45% |
| Dec 31, 2024 | -53.21% |
| Sep 30, 2024 | -66.71% |
| Jun 30, 2024 | -25.32% |
| Mar 31, 2024 | -46.64% |
| Dec 31, 2023 | -41.89% |
| Sep 30, 2023 | -34.95% |
| Jun 30, 2023 | -1.85% |
| Mar 31, 2023 | -9.91% |
| Dec 31, 2022 | -5.68% |
| Sep 30, 2022 | 16.95% |
| Jun 30, 2022 | 9.11% |
| Mar 31, 2022 | -15.50% |
| Dec 31, 2021 | 3.71% |
| Sep 30, 2021 | 13.06% |
| Jun 30, 2021 | 1.55% |
| Mar 31, 2021 | 13.20% |
| Dec 31, 2020 | -2.31% |
| Sep 30, 2020 | 20.12% |
| Jun 30, 2020 | 28.40% |
| Mar 31, 2020 | 4.80% |
| Sep 30, 2019 | 10.06% |
| Jun 30, 2019 | 20.20% |
| Mar 31, 2019 | -19.07% |
| Sep 30, 2018 | -2.29% |
| Jun 30, 2018 | 6.47% |
| Mar 31, 2018 | -33.82% |
| Sep 30, 2017 | -20.23% |
| Jun 30, 2017 | -41.52% |
| Mar 31, 2017 | -18.53% |
| Sep 30, 2016 | -24.27% |
| Jun 30, 2016 | -39.90% |
| Mar 31, 2016 | 9.00% |
| Sep 30, 2015 | -27.00% |
| Jun 30, 2015 | -24.17% |
| Mar 31, 2015 | -7.76% |
| Sep 30, 2014 | -23.41% |
| Jun 30, 2014 | -19.35% |
| Mar 31, 2014 | -23.28% |
| Dec 31, 2013 | -29.17% |